3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
23
Phase 2
12
Phase 1/2
6
Phase NA
4
Phase 3
2
Phase EARLY_PHASE1
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
2
Thoracic
1
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
75
Lung Neoplasms
48
Small Cell Lung Carcinoma
11
Neoplasms
10
NSCLC
8
Colorectal Neoplasms
7
Prostatic Neoplasms
6
Ovarian Neoplasms
6
Brain Neoplasms
6
Mesothelioma
5
Breast Neoplasms
5
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Head and Neck Neoplasms
4
Adenocarcinoma of Lung
4
Liver Neoplasms
3
Hematologic Neoplasms
3
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Thyroid Cancer, Papillary
2
Sarcoma
2
Recurrence
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Multiple Myeloma
2
Laryngeal Neoplasms
2
Interventions
pertuzumab
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Salivary Gland Neoplasms
×
Thoracic
×
Clear all
NCT05786716
2025-12-02
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled